Commentary
Experts share key takeaways on data presented at the 2019 Crohn’s & Colitis Congress.
Research Advances and Clinical Impact of New Data From Crohn’s & Colitis Congress® 2019
Main Program Page: https://www.clinicaloptions.com/LasVegas2019
Disease and Drug Monitoring in IBD: My Take on Data From Crohn’s & Colitis Congress 2019
By D. Brent Polk, MD, AGAF
ClinicalThought Commentary activity link: https://www.clinicaloptions.com/immunology/conference-coverage/lasvegas2019/clinicalthought/ct1/page-1
New and Emerging IBD Treatments: Our Take on Data From Crohn’s & Colitis Congress 2019
By Baldeep S. Pabla, MD, MSCI and Davida A. Schwartz, MD, FACG, AGAF
ClinicalThought Commentary activity link: https://www.clinicaloptions.com/immunology/conference-coverage/lasvegas2019/clinicalthought/ct2/page-1
